Literature DB >> 32944454

An Interesting Case of Moyamoya Disease, a Rare Cause of Transient Ischemic Attacks.

Amit Sapra1, Priyanka Bhandari1, Rebecca Dix1, Shivani Sharma1, Eukesh Ranjit1.   

Abstract

Moyamoya disease is a rare, chronic, idiopathic progressive disease characterized by irreversible vascular occlusion of the vessels of the Circle of Willis. The disease was initially considered to be limited to the East Asian population, but now the disease is being reported all over the globe in people of multiple ethnicities. It is crucial that clinicians are aware of the disease and its presentation to prevent under-recognition of the condition. We describe the case of a 44-year-old Caucasian female with a history of hypertension, depression, gastroesophageal reflux disease (GERD), and morbid obesity diagnosed with Moyamoya disease after she presented to the emergency department with recurrent stroke-like symptoms.
Copyright © 2020, Sapra et al.

Entities:  

Keywords:  acute cva; brain mri; cerebrovascular accidents; computed tomography angiography; diagnostic cerebral angiogram; intracerebral hemorrhage; moyamoya disease; rare disorder; strokes; transient ischemic attack (tia)

Year:  2020        PMID: 32944454      PMCID: PMC7489789          DOI: 10.7759/cureus.9736

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis?

Authors:  Yasuyuki Kaku; Motohiro Morioka; Yuki Ohmori; Takayuki Kawano; Yutaka Kai; Hirofumi Fukuoka; Toshinori Hirai; Yasuyuki Yamashita; Jun-ichi Kuratsu
Journal:  Acta Neurochir (Wien)       Date:  2012-08-31       Impact factor: 2.216

Review 2.  Moyamoya Disease: A Review of Clinical Research.

Authors:  Tomohito Hishikawa; Kenji Sugiu; Isao Date
Journal:  Acta Med Okayama       Date:  2016-08       Impact factor: 0.892

Review 3.  Surgical Management of Moyamoya Disease.

Authors:  Güliz Acker; Lucius Fekonja; Peter Vajkoczy
Journal:  Stroke       Date:  2018-01-17       Impact factor: 7.914

Review 4.  Meta-Analysis of Prognosis of Different Treatments for Symptomatic Moyamoya Disease.

Authors:  Qifeng Li; Yalong Gao; Wenqiang Xin; Ziwei Zhou; Hongtao Rong; Yafei Qin; Ke Li; Yuan Zhou; Jiwei Wang; Jianhua Xiong; Xinlong Dong; Mengchen Yang; Yixin Liu; Jun Shen; Guangen Wang; Aiguo Song; Jianning Zhang
Journal:  World Neurosurg       Date:  2019-04-14       Impact factor: 2.104

Review 5.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

Review 6.  Moyamoya Disease.

Authors:  Miki Fujimura; Oh Young Bang; Jong S Kim
Journal:  Front Neurol Neurosci       Date:  2016-12-02

Review 7.  Endovascular treatment of symptomatic moyamoya.

Authors:  Bradley A Gross; Ajith J Thomas; Kai U Frerichs
Journal:  Neurosurg Rev       Date:  2014-04-03       Impact factor: 3.042

Review 8.  Moyamoya Disease: Treatment and Outcomes.

Authors:  Tackeun Kim; Chang Wan Oh; Jae Seung Bang; Jeong Eun Kim; Won-Sang Cho
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

9.  Hemorrhagic Moyamoya Disease : A Recent Update.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  J Korean Neurosurg Soc       Date:  2018-11-15

Review 10.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

  10 in total
  1 in total

1.  Identification of associations and distinguishing moyamoya disease from ischemic strokes of other etiologies: A retrospective case-control study.

Authors:  Cori Xiu Yue Sutton; Enrique Carrazana; Catherine Mitchell; Jason Viereck; Kore Kai Liow; Arash Ghaffari-Rafi
Journal:  Ann Med Surg (Lond)       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.